Table 3.
Cox proportional analysis for 5-year mortality in all cohort population
| Variable | HR (95% CI) | p value |
|---|---|---|
| Age, yr | 1.04 (1.03–1.05) | < 0.001 |
| Male sex | 1.12 (0.96–1.31) | 0.144 |
| Diabetes | 1.88 (1.59–2.21) | < 0.001 |
| Congestive heart failure | 1.53 (0.98–2.39) | 0.060 |
| Cardioprotective medicationa | 1.16 (1.00–1.36) | 0.051 |
| Albumin < 3.5 g/dL | 1.43 (1.22–1.68) | < 0.001 |
| Hemoglobin < 10.0 g/dL | 1.17 (1.00–1.37) | 0.045 |
| Percutaneous catheter (ref. AV access) | 1.78 (1.44–2.21) | < 0.001 |
| Tunneled cuffed catheter (ref. AV access) | 1.64 (1.36–1.98) | < 0.001 |
HR, hazard ratio; CI, confidence interval; AV, arteriovenous.
a
One of following: β-blocker, calcium channel blocker, angiotensin converting enzyme inhibitor, angiotensin receptor antagonist medication.